Mergers and Aquisitions Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.64Cu-GRIP B in Patients With Advanced Genitourinary Malignancies
Conditions: Prostate Cancer; Renal Cancer; Urethral Cancer Interventions: Drug: Copper-64 labeled Granzyme B (64Cu-GRIP B); Procedure: Positron Emission Tomography (PET) Sponsors: Rahul Aggarwal; National Cancer Institute (NCI); U.S. Army Medical Research Acquisition Activity Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 5, 2023 Category: Research Source Type: clinical trials
Testing the Addition of an Anti-cancer Drug, SNDX-5613, to the Standard Chemotherapy Treatment (Daunorubicin and Cytarabine) for Newly Diagnosed Patients With Acute Myeloid Leukemia That Has Changes in NPM1 or MLL/KMT2A Gene
Conditions: Acute Myeloid Leukemia With KMT2A Rearrangement; Acute Myeloid Leukemia With NPM1 Mutation Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Drug: Cytarabine; Drug: Daunorubicin; Procedure: Multigated Acquisition Scan; Drug: Revumenib; Procedure: Transthoracic Echocardiography Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
